Safety of Neoadjuvant Immunotherapy in Resectable Cancers: A Meta-Analysis

BACKGROUND: Neoadjuvant immunotherapy has preliminarily been effective in multiple resectable cancers. However, its safety is still largely unknown. METHODS: A systematic literature search was conducted in PubMed, Embase, Web of Science, and Cochrane Library up to February 28th, 2021. Pooled inciden...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiawei, Wu, Yongfeng, Xu, Yuedan, Qiu, Yuan, Li, Xiaobo, Song, Yumeng, Zhang, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841351/
https://www.ncbi.nlm.nih.gov/pubmed/35173721
http://dx.doi.org/10.3389/fimmu.2022.802672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841351/
https://www.ncbi.nlm.nih.gov/pubmed/35173721
http://dx.doi.org/10.3389/fimmu.2022.802672

Ejemplares similares